Stacey Obrien, MD
Family Medicine · Woodstock, GANPI 1164843389
Payments from drug & device makers
Across 292 payments — averaging $17.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$1K
- AstraZeneca$724
- AbbVie$602
- Lilly USA, LLC$589
- GSK$300
- Astellas Pharma US Inc$275
- plus $2K from 25 others
What the payments were for
- Food & beverage$5,04699%
- Education$451%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 70 | $1,049 |
| AstraZeneca | 43 | $724 |
| AbbVie(2 entities) | 36 | $602 |
| Lilly USA, LLC | 31 | $589 |
| GSK | 14 | $300 |
| Astellas Pharma US Inc | 12 | $275 |
| Merz North America, Inc. | 2 | $198 |
| Amgen | 10 | $155 |
| Insulet Corporation | 18 | $152 |
| Exact Sciences | 9 | $152 |
| Boehringer Ingelheim | 5 | $101 |
| Pfizer | 4 | $79 |
| Antares Pharma, Inc. | 4 | $77 |
| Abbott | 4 | $67 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 3 | $58 |
| Verity Pharmaceuticals Inc. | 3 | $54 |
| Dynavax Technologies Corporation | 2 | $51 |
| Globus Medical | 2 | $50 |
| Idorsia Pharmaceuticals US Inc | 3 | $49 |
| Merck | 3 | $43 |
| Almatica Pharma LLC | 2 | $39 |
| Inspire Medical Systems, Inc. | 2 | $38 |
| Sumitomo Pharma America, Inc. | 2 | $37 |
| Vivus LLC | 1 | $24 |
| Philips North America LLC | 1 | $21 |
| Biotronik NRO, Inc. | 1 | $20 |
| Halozyme Inc | 1 | $20 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $19 |
| Novartis | 1 | $18 |
| Nevro Corp. | 1 | $17 |
| Currax Pharmaceuticals LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- XEOMIN$127
How this compares
$5,091 in reported general payments places this provider in the 85th percentile of 3,111 family medicine providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 29 | $59,879 |
| EliquisApixaban | 46 | $46,252 |
| JardianceEmpagliflozin | 34 | $45,435 |
| TrulicityDulaglutide | 20 | $30,320 |
| FarxigaDapagliflozin Propanediol | 23 | $29,187 |
| MounjaroTirzepatide | 17 | $27,982 |
| RybelsusSemaglutide | 14 | $26,726 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 24 | $20,404 |
| MyrbetriqMirabegron | 20 | $13,091 |
| Bydureon BciseExenatide Microspheres | 12 | $9,984 |
| Breo ElliptaFluticasone/Vilanterol | 12 | $4,807 |
| Ezetimibe | 47 | $2,195 |
| Atorvastatin Calcium | 309 | $2,138 |
| Levothyroxine Sodium | 313 | $2,038 |
| Rosuvastatin Calcium | 119 | $1,651 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus | $1,049 | $86,60543 claims |
| Lilly USA, LLCTrulicity, Mounjaro | $589 | $58,30237 claims |
| AstraZenecaFarxiga, Breztri Aerosphere | $724 | $49,59247 claims |
| PfizerEliquis | $79 | $46,25246 claims |
| Boehringer IngelheimJardiance | $101 | $45,43534 claims |
| Astellas Pharma US IncMyrbetriq | $275 | $13,09120 claims |
| GSKBreo Ellipta | $300 | $4,80712 claims |
| AbbVieSynthroid | $602 | $92716 claims |
| Almatica Pharma LLCSertraline Hcl | $39 | $841102 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 3,111 family medicine providers in Georgia.
Other family medicine in Woodstock
- Joseph SurberColumbus$16.6M
- Angela RitterGainesville$15.8M
- Jeffrey KingsleyColumbus$8.1M
- Christopher OldfieldSavannah$6.4M
- Darrell MurrayAtlanta$3.9M
- Ben ThomasAtlanta$3.2M
- Debbie HaginsSavannah$2.1M
- Aziz PiraniLilburn$2.1M
- Nadia CameronAtlanta$2.1M
- John LentzSnellville$1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.